Cancer Therapy Advisor Institute Spotlight Course

The Evolving Landscape of Targeted Therapies for Metastatic Colorectal Cancer: New Frontiers of Personalized Cancer Care

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

1.00 CME CE: Current, evidence-based recommendations for targeted metastatic colorectal cancer therapies to manage individualized needs. Exp 3/8/24

NSCLC: Optimizing Immune Checkpoint Inhibitor Therapy | myCME

AAPA Category 1 CME Credit, ANCC Contact Hour(s), IPCE Credit(s)

1.00 CME CE: This CE/CME activity offers expert strategies to optimize Immune checkpoint inhibitors in Non-Small-Cell Lung Cancer individualized therapy and adverse events. Exp 7/13/23

Turning Complexity into Clarity in Advanced Cervical Cancer | myCME

AMA PRA Category 1 Credit(s)^TM

3.75 CME: This course provides vital information on the treatment of cervical cancer. Exp 7/19/23

Anti-TROP2 ADCs in Advanced TNBC Care | myCME

AMA PRA Category 1 Credit(s)^TM

0.50 CME: Discusses advanced TNBC and how novel anti-TROP2 antibody-drug conjugate (ADC) therapy may play a role. Exp 8/3/23

TNBC Case Challenges | myCME

AMA PRA Category 1 Credit(s)^TM

0.50 CME: Put your TNBC skills to the test in these interactive and challenging triple-negative breast cancer (TNBC) cases. Exp 8/3/23

Gastric Cancer Immunotherapy Treatments and AEs | myCME

AAPA Category 1 CME Credit, ANCC Contact Hour(s), IPCE Credit(s)

1.00 CME CE: Offers expert advice on treatment for advanced gastric cancer, with a focus on supporting data and adverse event management. Exp 8/14/23

Optimizing Outcomes of mHSPC Via TX Intensification | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s), CE for Pharmacists

1.00 CME CE: Provides education on individualized treatment plans for pts with mHSPC, using current guidelines and expert recommendations. Exp 10/26/23

Endoscopic Cryotherapy Abscopal Effect | myCME

AMA PRA Category 1 Credit(s)^TM

1.00 CME: Current uses and evidence behind some endoscopic cancer ablative therapy. Presents novel research on emerging endoscopic ablative therapies. Exp 12/8/23

Racial and Ethnic Disparities and Health Inequities in Lung Cancer | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category 1 CME Credit, CPEU Credit, ABIM MOC Points, CE for Case Manager

0.75 CME CE: Expert faculty discuss biases, disparities, and health inequities for racial and ethnic underserved patients with lung cancer. Exp. 10/25/23

Advanced Endometrial Cancer for the Oncology Nurse | myCME

ANCC Contact Hour(s)

CME 1.00: Helps oncology nurses understand the importance of biomarker testing and immune checkpoint inhibitors in endometrial cancer care. Exp 8/30/23

New Approaches in Head and Neck Squamous Cell Carcinoma | myCME

AAPA Category 1 CME Credit, ANCC Contact Hour(s), IPCE Credit(s)

1.00 CME CE: This CE/CME activity addresses key topics in the management of head and neck cancers, including a review of currently approved immune checkpoint inhibitors. Exp 7/19/23

HCC: Advances in Targeted Therapies and ICIs | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

1.00 CME CE: Latest developments and insights in managing HCC and tools to evaluate efficacy, safety, clinical effectiveness and application. Exp 8/16/23

Biomarkers in Managing Metastatic Colorectal Cancer | myCME

AMA PRA Category 1 Credit(s)^TM

1.00 CME: Dr. Benny Johnson, MD Anderson Cancer Center, focuses on biomarkers to inform selection of targeted and immunotherapies for mCRC. 10/7/23